University of Liverpool signs option agreement with BARD1 for type 3C diabetes test
The University of Liverpool has signed a two year option agreement with the Australian diagnostics company, BARD1 Life Sciences Ltd, for a type 3c diabetes (T3cDM) blood test. The test uses patented technology developed by researchers in the University of Liverpool s Institute of Systems, Molecular and Integrative Biology.
There are around 22.9 million new cases of new-onset diabetes diagnosed around the globe. T3cDM diabetes occurs in around 10 per cent of all new-onset diabetes cases. Currently, no test exists to identify T3cDM and it is most often misdiagnosed as type 2 diabetes (T2DM) and/or inappropriately managed. Approximately 10 in 100 people with T3cDM have underlying pancreatic cancer, with diabetes acting as an early warning sign for the presence of cancer.
Hair-raising effort by Corpach bike coach Norman generates cash obantimes.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from obantimes.co.uk Daily Mail and Mail on Sunday newspapers.
TWO local men have gone well out of their comfort zone and completed a marathon in brisk westerly winds raising more than £6,000 in aid of pancreatic cancer research. James Anderson and Richie Gardner set off from Quarff on Saturday morning and completed the 26.2-mile course at.